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ABSTRACT
Objective: The objective of this study was to optimize the best formula for fast release suppositories of diazepam.
Methods: Suppositories were prepared by fusion method using Witepsol H15 as oleaginous base, polyethylene glycol as water-soluble polymer and 
poloxamer 188 as water miscible base. All suppositories were evaluated for physical characteristics, in vitro drug release and kinetic models. The 
effects of incorporating Tween 80 as a nonionic surfactant, propylene glycol as a cosolvent, and effervescent pair on the release rate of diazepam from 
suppositories were investigated. Differential scanning calorimetry and Fourier transform infrared spectrometry were used to characterize physical 
mixtures of diazepam and the different used bases.
Results: Fast release of diazepam has been obtained from suppositories containing the effervescent pair. Many formulations of diazepam have been 
prepared and in vitro evaluated. PEG suppositories released diazepam more efficiently than poloxamer and Witepsol suppositories. The including of 
an effervescent pair in the formulation of suppositories greatly enhanced the release of diazepam. The addition of Tween 80 to Witepsol suppositories, 
PG to poloxamer suppositories, increased the rate and extent of diazepam release.
Conclusion: Fast release of diazepam has been obtained from suppositories containing the effervescent pair (formula F3), which also have good 
physical properties.
Keywords: Diazepam, Suppositories, Polyethylene glycol, Poloxamer 188, Witepsol H15, Tween 80, Propylene glycol, Effervescent pair.
INTRODUCTION
Diazepam is a long-acting benzodiazepine with anticonvulsant, sedative, 
and anxiolytic properties [1]. It is rapidly absorbed, enters the brain quickly 
and interrupts cerebral seizures of epilepsy within seconds to minutes. In 
general, diazepam, which is given intravenously, is the drug of choice for the 
emergency treatment of prolonged febrile seizures. However, it can only be 
administered in a hospital setting. Therefore, it is not an ideal medication to 
be given in the community by nonmedical personnel. Rectal formulations 
not only enable caregivers (parents, family) to treat uncontrolled seizures 
immediately but may also be administered by a physician when intravenous 
access is not possible. Rectal diazepam solutions have not been used 
widely because of the tendency to leak out of the rectum, which can lead 
to inaccurate dosing and treatment failure [2]. Diazepam in a conventional 
suppository is well absorbed, but its absorption is slow because of the 
slow release of the drug from the suppository bases. Studies have been 
conducted in an effort to determine how to increase the diazepam release 
rate from suppositories. The objective of this research was to develop the 
most effective rapid release diazepam suppository formulations.
MATERIALS AND METHODS
Materials
The following materials were used: Diazepam (Fabbrica Italiana Sintetici 
S.P.A, Milano, Italy), Polyethylene glycol (PEG 400, PEG 4000) (Riedel-De 
Haen Ag seelze-Hannover, Germany), Witepsol H15 (Dynamit Nobel, 
Leverkusen, Germany), Tween 80 (Riedel-De Haen Ag seelze-Hannover, 
Germany), Poloxamer 188 (Sigma-Aldrich, Germany), Sodium phosphate 
(Sigma-Aldrich, Germany). Propylene glycol (PG) (Ineo. Belgium), Citric 
acid (Scharlab, Spain), and Sodium bicarbonate (Scharlab, Spain).
Preparation of diazepam suppositories
Suppositories containing 2 mg of diazepam were prepared by the 
fusion method, using different hydrophilic (PEG, poloxamer 188) and 
lipophilic (Witepsol H15) bases. The bases were melted using a water 
bath. Diazepam powder was added with stirring until a homogeneous 
mixture was produced, and the mixture was poured into the metal 
suppository mold (each one of 1 ml capacity) and was left to cool.
The value of the displacement factor (f) (a measure of how much base 
is displaced by a unit weight of an API), was calculated for the formula 





Where E is the weight of the blank suppository containing only base, 
G is the weight of the suppository containing an effervescent pair in 
a known concentration, and x is the effervescent pair content of the 
suppository in weight percentage.






Where TM is the suppository base to be weighed, E is the calibration 
constant of the mold, f is the displacement factor of each component, 
and S is the weight of each component (Table 1).
Evaluation of the prepared diazepam suppositories
Weight variation
About 20 suppositories were weighed individually, and the average 
weights were determined. Up to 2 suppositories could deviate from 
average weight by more than 5% but not more than 10% [4].
© 2017 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2017.v10i9.19264
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Content uniformity
Five suppositories were selected randomly from each formula and assayed 
for the drug content. A suppository was added to 50 mL of phosphate 
buffer solution, pH 6.8, then melted with gentle heating and shaking in an 
ultrasonic water bath (PHYLO, USH-10D Italy) at 37°C. The volume was 
adjusted to 100 mL with phosphate buffer. Then, 2 mL were taken, and the 
volume was again adjusted with phosphate buffer to 10 mL. The ultraviolet 
(UV) absorbance of the final solution was measured spectrophotometrically 
at λmax 230 nm against a blank phosphate buffer solution [5].
Mechanical strength/crushing test
The test was used to measure the mass (in kilograms) that a suppository 
can bear without breaking. The suppository was positioned in an upright 
position, and increasing weights are placed on it until it loses its structure 
and collapses. The purpose of the test was to verify that the suppository 
can be transported under normal conditions and administered to the 
patient. A good result was at least 1.8-2 kg pressure [5].
Disintegration test
The disintegration test was achieved to determine whether the 
suppositories disintegrate within the prescribed time period. Each 
disintegrating device was placed in a beaker with a minimum capacity 
of 4 l, filled with water. The beaker was fitted with a slow stirrer and 
support that holds the device vertically 90 mm below the water surface 
so that it can be inverted without emerging from the water. Water was 
maintained at a temperature of 36-37°C as the immersion fluid. The 
test was performed on three suppositories from each formula [6], using 
disintegration tester (COPLEY type: NE4-COPD: UKʻNG42JY).
Determination of melting range
Many suppository bases and medicated suppositories are mixtures, 
and so do not have a precise melting point, that is why melting range or 
melting zone is the term often preferred by some rather than melting 
point. A number of different techniques are used to study melting 
behavior, including the open capillary tube, the U-tube, and the drop point 
methods [5]. The test was done using (BUCHI melting point B=540) [5].
Suppository penetration test
The temperature was adjusted to that required for the test (37°C). The 
suppository was placed in the device and the penetration rod gently 
moved into the appropriate place. The device holding the suppository 
and penetration rod was inserted into the constant temperature bath, and 
a stopwatch was started. When the penetration rod drops through the 
softened suppository, the time was recorded [5]. The test was done on three 
suppositories from each formula using penetration tester (Erweka. PM3).
In vitro release of diazepam from solid suppository bases
The USP rotating paddle dissolution apparatus (Pharma test PT-
DT7, Germany) was used at 37±0.5°C and 50 rpm for the in vitro 
release studies of diazepam from solid suppositories. The release 
test was done for 45 minutes in 500 ml phosphate buffer solution, 
pH 6.8. Samples, each of 5 mL, were withdrawn from the dissolution 
medium at specified time intervals (5, 10, 15, 20, 25, 30, and 
45 minutes) and replaced by fresh buffer. Wire sinker was used to 
prevent suppository from floating on the surface of the dissolution 
medium. The samples were filtered through Millipore filter (Pore 
size 0.45 Micron, Xiboshi, syringe filter, China) and analyzed 
spectrophotometrically at 230 nm against a blank phosphate buffer 
(U-1800 UV/VIS spectrophotometer, HITACHI, Japan). Each release 
experiment was performed in triplicate [7]. The validation process 
was done for the analytical method.
Kinetic analysis of release data
To describe the release models, in vitro release data from solid 
suppositories were analyzed according to a zero-order kinetic model, 
a first-order release model, a diffusion controlled model (Higuchi 
model), a Hixson-Crowell release model, and a Korsmeyer-Peppas 
model. The model that consistently produced the highest correlation 
among the suppository preparations was used for the assessment of 
drug release rates [8]. For Peppas model, the results were illustrated 
depending on n values, when (0.45<n<0.89) means a non-Fickian 
diffusion and when n=0.45 indicates Fickian diffusion (Higuchi 
model).
Statistical analysis of the drug release profiles
All the results were expressed as mean values ± standard deviation. The 
difference between percentages of diazepam released at specified time 
intervals, from the different formulations, were statistically evaluated 
using Student T-test. For results interpretation, p value was significant 
when p<0.05.
Differential scanning calorimetry (DSC)
DSC is one of the most unique tools to determine the interaction 
between the active pharmaceutical ingredient and the excipients [8]. 
Thermal properties of diazepam, PEG, poloxamer, Witepsol H15, and 
the physical mixtures of diazepam and each of the used excipients 
were studied, on a DSC (Mettler Toledo, USA). Samples (4-5 mg) 
were accurately weighed (±0.01 mg) and heated in closed aluminum 
crimp cells at a rate of 10°C/minute under nitrogen steam, at a flux 
rate of 100 ml/minute, over a temperature range from 25°C to 400°C. 
Measurements in triplicate were performed.
Fourier transform infrared spectrometry (FTIR)
The vibrational spectrum of a molecule is considered to be a unique 
physical property and is a characteristic of the molecule. As such, the 
infrared spectrum can be used as a fingerprint for identification by 
a comparison of the spectrum from an “unknown” with previously 
recorded reference spectra [9].
RESULTS AND DISCUSSION
Physical properties of the tested suppositories
The weight variations for all suppositories were found to be within 
the acceptable range (<5%) [6]. The drug content of suppositories, 
for each formulation, was in the acceptable range (85-115%) [4]. The 
mechanical strengths were more than 1.8 kg for all the formulations, 
showing optimum hardness for handling and transportation [5]. 
The melting ranges of all the investigated suppositories comply with 
the pharmacopeia requirements. The addition of Tween 80 leads 
to depression of the melting range of suppositories. The softening 
times of all suppositories were within 30 minutes, and that comply 
with the pharmacopeia limits [5], expect for F4 (poloxamer 100%) 
which had taken about 1 hr to soften or liquefy, and that is may be 
due to the gelling characteristics of poloxamer 188 (thermosensitive 
polymer) [10]. The disintegration time was within 30 minutes for 
Witepsol H15 suppositories and within 60 minutes for hydrophilic 
base suppositories, and that complies with the pharmacopeia limits 
(Table 2) [6].
Table 1: Composition of solid suppository formulations
Formula Diazepam  
(mg/supp.)
Suppository composition
F1 2 PEG 4000 50%+PEG 400 50%
F2 2 PEG 4000 50%+PEG 1500 35%+PEG 
400 15%
F3 2 PEG 4000 50%+PEG 1500 35%+PEG 
400 15%+effervescent pair 200 mg*
F4 2 Poloxamer 188 100%
F5 2 Poloxamer 188 70%+PG 30%
F6 2 Poloxamer 188 50%+PG 50%
F7 2 Witepsol H15 100%
F8 2 Witepsol H15 95%+Tween 80 5%
F9 2 Witepsol H15 90%+Tween 80 10%
*Effervescent pair is composed of citric acid 138 mg and NaHCO3 62 mg, 
PEG: Polyethylene glycol
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In vitro release rate of diazepam from water-soluble and water-
miscible bases
The dissolution profiles of diazepam from PEG formulas (F1, F2, and F3) 
are shown in Fig. 1. Statistical analysis revealed a significant difference 
(p<0.05) between formulas (F1, F2), at 5 minutes, and between (F2, F3) 
at 5, 10 minutes with respect to the studied release rates. Diazepam has 
reached its maximum release in about 15 minutes in formulas 1 and 2. 
The fastest release formula was F3, which contained an effervescent pair, 
in which diazepam reached its maximum release in about 5 minutes. 
The high release rate of diazepam from PEG suppositories may be due 
to both low affinity of the drug to the base and water solubility of the 
base, which allows the drug to be released by both diffusion and erosion 
mechanisms [11]. The dissolution of very slightly soluble substances, 
like diazepam, is usually the rate limiting step in the absorptive 
process, therefore as much as we can enhance the dissolution rate, the 
absorption will be improved [12]. The effervescent pair enhanced the 
release rate for (F3), so according to rates of diazepam release from 
PEG suppositories, the results were as follows: F3>F1>F2.
For poloxamer-based suppositories, the dissolution profiles are shown 
in Fig. 2. Statistical analysis revealed a significant difference (p<0.05) 
between formulas. Releasing rate of diazepam from formula 4 (with 
100% poloxamer 188) as a base was lower and slower than that from 
other poloxamer formulas (F5, F6) which contained (30% and 50%) PG, 
respectively. That is because poloxamer in formula 4 was gelatinized 
and has not dissolved in the dissolution medium, but in the presence of 
PG which has a hygroscopic property, water uptake was increased, and 
a hydrophilic matrix was formed [13]. That is why the dissolution rate 
results were as follows: F6>F5>F4.
In vitro release rate of diazepam from oleaginous bases (Witepsol 
H15)
The dissolution profiles of diazepam from fatty base suppositories 
(F7, F8, and F9) are shown in Fig. 3. Statistical analysis revealed a 
significant difference (p<0.05) between formulas. Diazepam could 
not be released from formula 7 (with 100% Witepsol H15), due to 
the strong affinity of the drug to the lipophilic base (Log p=2.82 for 
diazepam [14], and diazepam is classified as a Class II according to 
biopharmaceutics classification system BCS [15]), which result in 
a hindrance of diazepam molecules migration into the dissolution 
medium [16]. When Tween 80, which is a hydrophilic nonionic 
surfactant (HLB = 15), was incorporated, the dissolution rate was 
enhanced. Percent of drug released increased on increasing Tween 80 
concentration. That is because Tween 80 has lowered the interfacial 
tension and increased dispersion of suppository base in the dissolution 
medium [17]. However, the release rates were still slower than that 
observed with PEG based suppositories. Results were according to the 
release rates of diazepam as follows: F9>F8>F7.
Kinetic analysis results
From Table 3, according to r2 and n values, the release kinetic model 
of all suppositories complies with Higuchi and Cross Mayer Peppas. In 
all formulas, n is bigger than 0.45 and smaller than 0.89, this indicates 
a non-Fickian diffusion [18]. Therefore, the release has occurred 
probably by diffusion, swelling and erosion.
DSC results
The DSC thermograms of diazepam (Fig. 4) showed a single sharp 
endothermic peak at 131.51°C corresponding to the melting point of 
diazepam. Concerning the obtained thermogram from PEG 4000, a 
wide endothermic melting peak at 60.32°C was observed, this wideness 
could be due to the variation in the molecular weights of the polymer. 
DSC curves of the physical mixture of diazepam with PEG 4000 base 
(Fig. 5) showed only one endothermic peak at 60.32°C correlating 
Table 2: Physical characterization of the tested suppositories




F1 1.29±0.007 96±2 2±0.1 37-42 18.1±0.14 13.15±0.21
F2 1.32±0.004 95.7±0.92 2.9±0.11 40-45 19.17±0.15 14.33±0.05
F3 1.39±0.007 99.9±0.14 2.7±0.11 36-42 3.3±0.25 4.3±0.05
F4 0.99±0.009 97.5±0.71 3.5±0.11 45-55 61.2±0.32 42.75±0.35
F5 1.064±0.008 100±0.1 2.7±0.11 40-45 28.25±0.35 17±0.1
F6 1.129±0.01 100.9±2.6 2.1±0.23 32.5-36 25.75±0.35 3±0.1
F7 1.065±0.001 90±2 4±0.1 31-36 8.43±0.03 20±0.1
F8 1.075±0.004 92±0.71 3.6±0.1 30-35 6±0.1 14.75±0.35
F9 1.081±0.006 96±0.5 3.3±0.11 29-34 5.3±0.07 12.1±0.14
SD: Standard deviation
Fig. 1: Release profiles of diazepam from various hydrophilic 
polyethylene glycol bases
Fig. 2: Release profiles of diazepam from various poloxamer 188 
bases
Fig. 3: Release profiles of diazepam from various Witepsol H15 
bases
227
Asian J Pharm Clin Res, Vol 10, Issue 9, 2017, 224-230
 Alsamman and Othman 
with the melting of PEG with the absence of the endothermic peak of 
diazepam. This result suggests that crystalline diazepam has become 
in the amorphous state or in molecularly dispersed structure in 
PEG [19]. The same result was found when diazepam was in a physical 
mixture with poloxamer 188, where the physical mixture of diazepam 
with poloxamer base showed only one endothermic peak at 53.04°C, 
correlating with the melting of poloxamer with an absence of the 
endothermic peak of diazepam (Fig. 6). The thermogram of the physical 
Table 3: In vitro release kinetic parameters of diazepam from the studied suppositories
Formula Zero-order (r2) First-order (r2) Higuchi (r2) Hixon (r2) Peppas (n) Peppas (r2)
F1 0.967 0.938 0.99 0.948 0.560 0.99
F2 0.91 0.851 0.958 0.871 0.633 0.961
F3 Diazepam was released completely in about 5 minutes
F4 0.964 0.879 0.993 0.914 0.517 0.994
F5 0.695 0.62 0.8 0.645 0.54 0.84
F6 0.822 0.75 0.9 0.775 0.61 0.916
F7 Diazepam was not released during the test period
F8 0.982 0.964 0.982 0.971 0.5 0.98
F9 0.941 0.9 0.974 0.909 0.53 0.98
(r2) correlation coefficient
Table 4: The most important functional groups in diazepam 
chemical formula and their infrared absorption
Assignment Wavenumber (cm−1)
C=O carbonyl stretching 1681
C=C stretching 1313
Aromatic in plane C-H bend 1127
Out of plane C-H bend 836.9 and 786.7 and 738.7 and 705.5
C-N stretching 813.6
Fig. 4: Differential scanning calorimetry curve of pure diazepam
Fig. 5: Differential scanning calorimetry curve of diazepam, PEG 
4000, diazepam-PEG 4000 physical mixture
Fig. 6: Differential scanning calorimetry curve of diazepam, 
poloxamer 188, diazepam-poloxamer 188 physical mixture
Fig. 7: Differential scanning calorimetry curve of diazepam, 
Witepsol H15, diazepam-Witepsol H15 physical mixture
Fig. 8: Fourier transform infrared spectrometry spectra of 
diazepam
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Fig. 9: Fourier transform infrared spectra of diazepam, PEG 4000, and their physical mixture, respectively
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Fig. 10: Fourier transform infrared spectra of diazepam, poloxamer 188, and their physical mixture, respectively
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mixture of diazepam with Witepsol H15 (Fig. 7) showed also only one 
endothermic peak corresponding to the melting of Witepsol, with the 
absence of diazepam peak. That is may be because that diazepam was 
completely soluble in the Witepsol base [20].
FTIR spectrometry results
This is the basis of computer-based spectral searching. In the absence of 
a suitable reference database, it is possible to give a basic interpretation 
of the spectrum from first principles, leading to characterization, and 
possibly even identification of an unknown sample [10]. This is based 
on the fact that structural features of the molecule, whether they are 
the backbone of the molecule or the functional groups attached to the 
molecule, producing characteristics and reproducible absorptions in 
the spectrum. This information can indicate whether the backbone 
consists of linear or branched chains, as it is possible to determine 
if there is an unsaturation and/or aromatic rings in the structure. 
Finally, it is possible to deduce whether specific functional groups are 
present [21].
The FTIR spectrum of diazepam is shown in Fig. 8, and the most 
important functional groups are mentioned in Table 4. The bands 1680, 
1605, 1400, 1320, 740, 700, and 580 cm−1 appear to be characteristic 
of the 1, 4-benzodiazepine structure [18-20]. C=O stretch, a very 
strong infrared absorption band was observed about 1680 cm−1 in 
the spectra of diazepam [22]. C=N stretch, a weak band in the infrared 
spectra [22]. CH group vibrations, a methylene group at position 3 of 
the diazepine ring, has six modes of vibration, which can be described 
as symmetric and asymmetric stretching, a “scissors” deformation 
and wagging, twisting and rocking motions. The two stretching modes 
are usually found near 2850 and 2930 cm−1 in saturated aliphatic 
hydrocarbon groups. Aromatic C=C stretching modes, the 5-phenyl-1, 
4-benzodiazepines have both mono- and tri-substituted benzene rings, 
each of which has six aromatic C=C stretching modes. Several of these 
are expected in the 1300-1600 cm−1 region [22].
The most characteristic bands of PEG 4000 (Fig. 9) are 3441 cm−1 
which corresponds to O-H stretching. 2878 cm−1 corresponds to C-H 
stretching. 1343 cm−1 and 1464 cm−1 correspond to C-H bending. Finally, 
1094, 1240, and 1279 cm−1 correspond to O-H and COH stretching.
In the FTIR spectra of the physical mixture of diazepam and PEG 4000 
(Fig. 9), all absorption bands of diazepam were observed with a small 
shifting at out of plane C-H bends from 836 to 838 cm−1, whereas in PEG 
spectrum, absorption band at 958 cm−1 has been shifted to 960 cm−1, 
absorption band at 1097 has shifted to 1100 cm−1 complying with O-H 
and COH stretching, and band shifting from 1466 cm−1 to 1467 cm−1 
corresponding to C-H bending. This may indicate the formation of 
hydrogen bonds between diazepam and PEG 4000.
The most characteristic bands of poloxamer 188 (Fig. 10) are 
2880 cm−1 which correspond to C-H stretching, 1341 cm−1 and 1466 cm−1 
corresponds to C-H bending, and 1098 and 1279 cm−1 corresponds to 
O-H and COH stretching [23].
In the FTIR spectra of the physical mixture of diazepam and poloxamer 
188 (Fig. 10), all absorption bands of diazepam were observed with 
a small shifting (1°) from 1681 to 1682 cm−1, and no difference in 
poloxamer absorption bands has occurred.
CONCLUSION
To conclude, many formulations of diazepam have been prepared and 
in vitro evaluated. Diazepam physically interacted with PEG 4000, 
poloxamer 188, and Witepsol H15 according to DSC studies. The 
including of an effervescent pair in the formulation of suppositories 
(F3) greatly enhanced the release of diazepam. Moreover, the addition 
of Tween 80 has a favorable role in increasing the drug release.
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